IRIS
ARCESE, WILLIAM
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 66.638
AS - Asia 7.420
EU - Europa 5.983
SA - Sud America 1.112
AF - Africa 111
Continente sconosciuto - Info sul continente non disponibili 18
OC - Oceania 14
Totale 81.296
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 66.435
SG - Singapore 3.533
CN - Cina 1.420
DE - Germania 1.192
RU - Federazione Russa 941
BR - Brasile 900
IT - Italia 880
UA - Ucraina 796
HK - Hong Kong 790
IE - Irlanda 712
VN - Vietnam 564
FR - Francia 337
GB - Regno Unito 337
KR - Corea 288
FI - Finlandia 241
BD - Bangladesh 205
SE - Svezia 205
JP - Giappone 172
IN - India 113
CA - Canada 93
PL - Polonia 93
AR - Argentina 81
MX - Messico 56
NL - Olanda 56
ZA - Sudafrica 41
ES - Italia 40
IQ - Iraq 40
AT - Austria 38
ID - Indonesia 30
TR - Turchia 28
UZ - Uzbekistan 28
CO - Colombia 25
BE - Belgio 23
EC - Ecuador 23
PH - Filippine 23
PK - Pakistan 23
MA - Marocco 21
CL - Cile 18
CZ - Repubblica Ceca 18
MY - Malesia 17
PY - Paraguay 17
CR - Costa Rica 16
AE - Emirati Arabi Uniti 15
UY - Uruguay 15
VE - Venezuela 15
EU - Europa 14
IR - Iran 14
JM - Giamaica 14
KE - Kenya 14
SA - Arabia Saudita 14
TH - Thailandia 14
AU - Australia 12
IL - Israele 12
PE - Perù 12
NP - Nepal 11
KZ - Kazakistan 10
LT - Lituania 10
BY - Bielorussia 9
DZ - Algeria 8
TW - Taiwan 8
EG - Egitto 7
JO - Giordania 7
PA - Panama 7
TN - Tunisia 7
AL - Albania 6
CH - Svizzera 6
KG - Kirghizistan 6
PT - Portogallo 6
AZ - Azerbaigian 5
BG - Bulgaria 5
BO - Bolivia 5
GR - Grecia 5
RO - Romania 5
DK - Danimarca 4
HU - Ungheria 4
SN - Senegal 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
HN - Honduras 3
LB - Libano 3
LK - Sri Lanka 3
QA - Qatar 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BH - Bahrain 2
CY - Cipro 2
DO - Repubblica Dominicana 2
EE - Estonia 2
ET - Etiopia 2
GE - Georgia 2
GT - Guatemala 2
HR - Croazia 2
MD - Moldavia 2
MN - Mongolia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
Totale 81.273
Salva come PNG Salva come JPEG
Città #
Wilmington 17.995
Woodbridge 17.265
Houston 16.018
Fairfield 2.123
Singapore 1.813
Ann Arbor 1.508
Ashburn 1.263
Chandler 943
San Jose 878
Seattle 816
Hong Kong 774
Cambridge 725
Dublin 686
Jacksonville 686
Beijing 610
Medford 534
Dearborn 455
Santa Clara 334
New York 303
The Dalles 268
Lawrence 253
Rome 241
Los Angeles 195
Moscow 195
Lauterbourg 185
Ho Chi Minh City 177
San Diego 148
Buffalo 137
Council Bluffs 136
Tokyo 135
Hanoi 131
Regensburg 128
Dallas 117
Mülheim 105
Milan 93
Helsinki 86
São Paulo 78
Orem 71
Zhengzhou 68
Menlo Park 62
London 59
Munich 57
Norwalk 45
Chicago 44
Kraków 42
Warsaw 41
Redwood City 40
Hefei 37
Redondo Beach 37
Falls Church 36
Guangzhou 36
Nuremberg 35
University Park 34
Nanjing 33
Frankfurt am Main 32
Boardman 31
Hangzhou 31
Atlanta 30
Toronto 29
Haiphong 27
Johannesburg 27
Chennai 26
Denver 26
Saint Petersburg 25
Seoul 25
Detroit 24
Kunming 24
Rio de Janeiro 24
Brooklyn 23
Da Nang 23
North Bergen 23
Redmond 23
Belo Horizonte 22
Montreal 22
Brussels 20
Mountain View 20
Mumbai 20
San Francisco 19
Poplar 18
Shanghai 18
Jakarta 17
New Delhi 17
Tashkent 17
Verona 17
Brno 16
Phoenix 16
Nanchang 15
San José 15
Baghdad 14
Columbus 14
Elk Grove Village 14
Bari 13
Curitiba 13
Hounslow 13
Palo Alto 13
Philadelphia 13
Amsterdam 12
Brasília 12
Engelhard 12
Guarulhos 12
Totale 70.231
Salva come PNG Salva come JPEG
Nome #
Unrelated cord blood transplant in children with high-risk acute lymphoblastic leukemia: a long-term follow-up 686
Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia 632
Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor 577
Pre-transplant prognostic factors for patients with high-risk leukemia undergoing an unrelated cord blood transplantation 570
Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day+5 responders and no advantage for nonresponders receiving anti-thymocyte globulin 536
Peripheral blood stem cell collection from G-CSF-stimulated unrelated donors for second transplant 527
Bowel ultrasonography as an aid for diagnosis of intestinal acute graft-versus-host-disease after allogeneic haematopoietic stem cell transplantation 509
A prospective molecular study of chimaerism in patients with haematological malignancies receiving unrelated cord blood or bone marrow transplants: detection of mixed chimaerism predicts graft failure with or without early autologous reconstitution in cord blood recipients 492
High levels of antiphospholipid antibodies are associated with cytomegalovirus infection in unrelated bone marrow and cord blood allogeneic stem cell transplantation 488
Hematopoietic stem cell transplantation for adults with acute promyelocytic leukemia in the ATRA era: a survey of the European Cooperative Group for Blood and Marrow Transplantation 488
High expression levels of vla-4 (CD49d) on mobilised peripheral blood stem cells are associated with rapid engraftment in multiple myeloma patients receiving autologous transplant 487
Hematopoietic, Mesenchymal, and Immune Cells Are More Enhanced in Bone Marrow than in Peripheral Blood from Granulocyte Colony-Stimulating Factor Primed Healthy Donors 478
High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from the Rome transplant network. 477
A new system for quality control in hematopoietic progenitor cell units before reinfusion in autologous transplant 475
Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice 471
Splenic irradiation before hematopoietic stem cell transplantation for chronic myeloid leukemia: long-term follow-up of a prospective randomized study 469
Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft- versus-host disease prophylaxis in haploidentical transplant 466
Fibrin glue for refractory hemorrhagic cystitis after unrelated marrow, cord blood, and haploidentical hematopoietic stem cell transplantation 465
ALL R-87 protocol in the treatment of children with acute lymphoblastic leukaemia in early bone marrow relapse 463
Cord blood transplantation in adults with acute myeloid leukaemia. 463
A fatal case of invasive fungal sinusitis by Scopulariopsis acremonium in a bone marrow transplant recipient 462
Clinical and metabolic effects of different parenteral nutrition regimens in patients undergoing allogeneic bone marrow transplantation 461
Monitoring of KI and WU polyomaviruses in hematopoietic stem cell transplant patients 461
Cryotherapy reduces oral mucositis and febrile episodes in myeloma patients treated with high-dose melphalan and autologous stem cell transplant: a prospective, randomized study 459
3-Tesla MR spectroscopy in patients subjected to bone marrow transplantation: clinical correlations. 456
Impact of ABO incompatibility on patient outcome in haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia - a report from the acute leukemia working party of the EBMT 456
The policy of the Rome Transplant Network (RTN), a metropolitan (2009). The Potential Application Of The Allogeneic Transplant By The Policy Of Widespread Donor Search: An Intention-To-Treat Analysis From The Rome Transplant Network. 455
Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study 451
Excretion of the novel polyomaviruses KI and WU in the stool of patients with hematological disorders 450
Obstacles to managing chemotherapy-induced nausea and vomiting in high-dose chemotherapy with stem cell transplant 449
Factors predicting outcome after allogeneic transplant in refractory acute myeloid leukemia: a retrospective analysis of Gruppo Italiano Trapianto di Midollo Osseo (GITMO) 449
Ponatinib Induces a Persistent Molecular Response and Graft-versus-Host Disease/Graft-versus-Leukemia Effect in a Patient with Philadelphia-Positive Acute Lymphoblastic Leukemia with a T315I Mutation following Early Relapse after Allogeneic Transplant 446
The potential role of pre-transplant HBcIgG seroposivity as predictor of clinically relevant cytomegalovirus infection in patients with lymphoma undergoing autologous hematopoietic stem cell transplantation: A study from the Rome Transplant Network 445
The therapeutic use of cord blood 445
Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells 440
Pre-transplant manipulation processing of umbilical cord blood units: Efficacy of Rubinstein's thawing technique used in 40 transplantation procedures 440
Sezary syndrome in relapse after reduced intensity allogeneic transplant successfully treated with donor lymphocyte infusion 438
Platelet gel for treatment of mucocutaneous lesions related to graft-versus-host disease after allogeneic hematopoietic stem cell transplant 436
Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation 436
WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO) 436
Fractionated total body irradiation in allogeneic bone marrow transplantation in leukemia patients: analysis of prognostic factors and results in 136 patients 434
Thiotepa-based conditioning for allogeneic stem cell transplantation in acute lymphoblastic leukemia—A survey from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation 434
Thrombophilic screening in patients with paroxysmal nocturnal haemoglobinuria: a pilot study 432
Higher incidence of relapse in patients with acute myelocytic leukemia infused with higher doses of CD34+ cells from leukapheresis products autografted during the first remission. 431
Impact of conditioning intensity in T-replete haplo-identical stem cell transplantation for acute leukemia: a report from the acute leukemia working party of the EBMT 430
CD34+ cell mobilization for allogeneic progenitor cell transplantation: efficacy of a short course of G-CSF 429
Pre-transplant persistence of minimal residual disease does not contraindicate allogeneic stem cell transplantation for adult patients with acute myeloid leukemia 429
Pregnancy and secondary cancer after allogeneic bone marrow transplantation 428
A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia 428
Stem cell transplantation for chronic myeloid leukemia in children 427
Transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical siblings in adult patients with acute myeloid leukemia and acute lymphoblastic leukemia 426
Cidofovir for BK virus-associated hemorrhagic cystitis: a retrospective study 424
Increasing risk of relapse after allogeneic stem cell transplant for adult acute lymphoblastic leukemia in > or = 2nd complete remission induced by highly intensive chemotherapy 423
Algorithm for donor selection in 2011 422
HLA-identical sibling allogeneic peripheral blood stem cell transplantation with reduced intensity conditioning compared to autologous peripheral blood stem cell transplantation for elderly patients with de novo acute myeloid leukemia 421
Cytogenetic and molecular diagnostic characterization combined to post-consolidation minimal residual disease assessment by flow-cytometry improves risk stratification in adult acute myeloid leukemia 420
The Rome Transplant Network model compared to the Italian Bone Marrow Donor Registry activity for unrelated donor search process and transplant efficiency for hematologic malignancy 420
Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia. 418
Hospital cluster of HBV infection: molecular evidence of patient-to-patient transmission through lancing device 417
Gastrointestinal surgical emergencies in patients treated for hemathological malignancies 417
Evaluation of a disease risk index for adult patients undergoing umbilical cord blood transplantation for haematological malignancies 417
Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia:a retrospective analysis. 416
ABO-incompatible bone marrow transplantation: a GITMO survey of current practice in Italy and comparison with the literature 416
Impact of Graft-versus-Host Disease Prophylaxis on Outcomes after Myeloablative Single-Unit Umbilical Cord Blood Transplantation 416
Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: a multicenter randomized trial from the Italian Group for Bone Marrow Transplantation 415
Matched and mismatched unrelated donor compared to autologous stem cell transplantation for acute myeloid leukemia in first complete remission: a retrospective, propensity score-weighted analysis from the ALWP of the EBMT 414
Relevance of bone marrow cell dose on allogeneic transplantation outcomes for patients with acute myeloid leukemia in first complete remission: results of a European survey 413
Allogeneic stem cell transplantation for agnogenic myeloid metaplasia: a European Group for Blood and Marrow Transplantation, Société Française de Greffe de Moelle, Gruppo Italiano per il Trapianto del Midollo Osseo, and Fred Hutchinson Cancer Research Center Collaborative Study 413
Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord-Cord Blood Transplant Group 413
Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia 412
Allogeneic stem cell transplantation for patients with advanced primary cutaneous T-cell lymphoma 411
Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study 410
Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO/EBMT randomized trial 409
Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia 408
Reduced intensity allogeneic transplantation in primary cutaneous t-cell lymphomas. 408
Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: influence of dose and stem cell source shows better outcome with rich marrow 407
Clinical and biological aspects of acute monocytic leukemia (a retrospective study of 29 patients) 407
Allogeneic stem cell transplant from HLA-identical sibling for chronic granulomatous disease and review of the literature 404
Development of cellulitis caused by Aeromonas hydrophila in allogeneic hematopoietic transplantation: a case report. 404
Total parenteral nutrition enriched with glutamine and ω-3 fatty acid in adult patients undergoing autologous stem cell transplantation. 403
Umbilical Cord Blood Transplantation From Unrelated Donors In Patients With Ph-Positive Acute Lymphoblastic Leukemia. 402
Standard- versus high-dose lenograstim in adults with hematologic malignancies for peripheral blood progenitor cell mobilization. 401
N-acetylcysteine in the treatment of steroid-resistant acute graft-versus-host-disease: preliminary results. Gruppo Italiano Trapianto di Midollo Osseo (GITMO) 401
Assessment of donor-derived kir by sequential cDNA genotyping in non t cell depleted haploidentical stem cell transplanted patients 401
Monitoring of minimal residual disease in acute myeloid leukemia 399
Minimal Residual Disease in Acute Myeloid Leukemia of Adults: Determination, Prognostic Impact and Clinical Applications 399
High-dose therapy and autologous stem-cell transplantation in waldenstrom macroglobulinemia: the lymphoma working party of the european group for blood and marrow transplantation 399
The potential role of pre-transplant HBcIgG seroposivity as predictor of clinically relevant cytomegalovirus infection in patients with lymphoma undergoing autologous hematopoietic stem cell transplantation: A study from the Rome Transplant Network. 398
Bone mass, bone metabolism, and prevalence of spinal fractures in recipients of allogenic bone marrow transplantation for leukemia 397
Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis 397
Management of advanced acute lymphoblastic leukemia in children and adults: results of the ALL R-87 protocol. AIEOP and GIMEMA Cooperative Groups 397
HLA-C and HLA-DQB1 compatibility in unrelated cord blood transplants 397
Monitoring treatment and survival in chronic myeloid leukemia. Italian Cooperative Study Group on Chronic Myeloid Leukemia and Italian Group for Bone Marrow Transplantation 397
Involvement of central nervous system in adult patients with acute myeloid leukemia: Incidence and impact on outcome 397
A single high dose of idarubicin combined with high-dose ARA-C for treatment of first relapse in childhood 'high-risk' acute lymphoblastic leukaemia: a study of the AIEOP group 396
Extracorporeal photochemotherapy in the treatment of acute and chronic GvHD: experience from Rome Transplant Network 395
Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation 394
Unrelated donor marrow transplantation: an update of the experience of the Italian Bone Marrow Group (GITMO) 394
Killer Cell Immunoglobulin-Like Receptor-Ligand Matching and Outcomes after Unrelated Cord Blood Transplantation in Acute Myeloid Leukemia 394
Outcome of patients activating an unrelated donor search: the impact of transplant with reduced intensity conditioning in a large cohort of consecutive high-risk patients 393
Totale 43.864
Salva come PNG Salva come JPEG
Categoria #
all - tutte 191.874
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 191.874
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021103 0 0 0 0 0 0 0 0 0 0 0 103
2021/20222.443 109 366 110 102 66 192 140 138 143 154 168 755
2022/20232.748 352 238 134 261 170 655 325 133 213 17 189 61
2023/20241.008 99 47 78 25 101 232 57 39 28 23 16 263
2024/20255.336 170 1.243 571 316 66 225 449 212 536 582 467 499
2025/20268.161 573 501 1.069 678 698 305 1.033 966 1.044 650 370 274
Totale 81.900